StockData

OSR Health, Inc. (OSRH) shareholders

OSRHOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as OSRHW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.21−0.02 (-7.08%)

Close on Oct 19, 2026Market cap $6.83MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
1M
Shares held, 13F filers
Institutional holders
13
5 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Kuk Hyoun Hwang
Joint filing with Bellevue Capital Management LLC (87.70%), Bellevue Global Life Science Investors, LLC (58.40%) and 1 more
2,035,00087.70%13G (passive) amendmentDec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of OSRHValueChange% of portfolio
Vanguard Fiduciary Trust Co148,266–$46.85K+131,2370.00%
Citadel Advisors LLC127,810–$40.43KNew0.00%
Jane Street Group, LLC127,195–$40.23KNew0.00%
Geode Capital Management, LLC100,458–$31.77K−5,2850.00%
Two Sigma Securities, LLC46,537–$14.72KNew0.00%
Vanguard Capital Management LLC37,373–$11.81K–0.00%
XTX Topco Ltd32,380–$10.24K−28,3660.00%
Susquehanna International Group, Llp18,282–$5.78KNew0.00%
Northern Trust Corp10,906–$3.45KNew0.00%
Mint Tower Capital Management B.V.7,500–$2.00K–0.00%
Tower Research Capital LLC (TRC)6,587–$2.08K+2,4460.00%
UBS Group AG580–$183−3,8960.00%
SBI Securities Co., Ltd.137–$43+600.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 2026131M5 / 33 / 30M0M
Q1 2026110M5 / 32 / 40M0M
Q4 2025110M5 / 12 / 20M0M
Q3 202580M4 / 20 / 40M0M
Q2 202580M2 / 31 / 20M0M
Q1 202580M8 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

4 funds held OSRH in Q2 2026, 31% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of OSRHValue% of fundAs of
Fidelity Extended Market Index Fund73,009–$31.80K0.00%May 31, 2026
Vanguard Extended Market Index Fund37,373–$11.82K0.00%Jun 30, 2026
Fidelity Series Total Market Index Fund6,773–$2.95K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund4,318–$1.88K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Kuk Hyoun HwangPresident and CEO, Director, 10% owner24,317,738Feb 19, 2025
Yeiseok KimChief Operating Officer24,699Apr 16, 2026
Sang Harry KimSee Remarks–Feb 21, 2025
Gihyoun BangChief Financial Officer–Feb 20, 2025
Reto Kaspar FierzDirector–Oct 24, 2025
Joong Myung ChoDirector–Feb 21, 2025
Alcide BarberisDirector–Feb 21, 2025
Hyuk Joo JeeDirector–Feb 20, 2025
Capital Management LLC Bellevue10% owner3,123,970Feb 19, 2025
Europe AG BCM10% owner7,531,634Feb 19, 2025
Global Life Science Investors LLC Bellevue10% owner2,043,500Feb 19, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2025Other+43,000––2,043,500
Kuk Hyoun Hwang
President and CEO, Director, 10% owner
Feb 14, 2025Other+7,531,634––9,575,134
Kuk Hyoun Hwang
President and CEO, Director, 10% owner
Feb 14, 2025Other+3,123,970––12,699,104
Kuk Hyoun Hwang
President and CEO, Director, 10% owner
Feb 14, 2025Other+43,000––2,043,500
Global Life Science Investors LLC Bellevue
10% owner
Mar 23, 2023Other−20,000––2,000,500
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Mar 23, 2023Other−20,000––2,000,500
David Jin Yoo
Chief Financial Officer
Mar 23, 2023Award+20,000––20,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 21, 2023Other−4,500––2,020,500
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 21, 2023Other+225,000––2,025,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 21, 2023Other−4,500––2,020,500
Global Life Science Investors LLC Bellevue
10% owner
Feb 21, 2023Other+225,000––2,025,000
Hosun Euh
Director
Feb 14, 2023Award+20,000––20,000
Steven Reed
Director
Feb 14, 2023Award+20,000––20,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 14, 2023Other−30,000––1,370,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 14, 2023Other−225,000––1,400,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 14, 2023Other−20,000––1,625,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 14, 2023Award+430,000$10.00$4.30M1,800,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 14, 2023Other−20,000––1,665,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 14, 2023Other−20,000––1,685,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 14, 2023Other−20,000––1,705,000
Kuk Hyoun Hwang
Chief Executive Officer, Director, 10% owner
Feb 14, 2023Other−20,000––1,645,000
Jin Whan Park
Director
Feb 14, 2023Award+20,000––20,000
Rad Roberts
Director
Feb 14, 2023Award+20,000––20,000
In Chul Chung
Director
Feb 14, 2023Award+20,000––20,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2023Other−20,000––1,645,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2023Other−30,000––1,370,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2023Other−225,000––1,400,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2023Other−20,000––1,625,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2023Award+430,000$10.00$4.30M1,800,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2023Other−20,000––1,665,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2023Other−20,000––1,685,000
Global Life Science Investors LLC Bellevue
10% owner
Feb 14, 2023Other−20,000––1,705,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
1M shares short
Days to cover
1.5
At 0M shares a day
Change since last report
-23.3%
From 1M shares
Short volume, 20 days
56.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of OSR Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 467,202 shares on Aug 26, 2026 over the last 90 days.

See a number that looks wrong?